RESULTS	Carraguard use was not associated with abnormal genital findings , other abnormal clinical findings , markers of genital inflammation , epithelial sloughing or microhemorrhage , or self-reported symptoms in women and men , or with abnormal vaginal flora or genital shedding of HIV-1 RNA in women .\